Related Experiment Videos
Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis.
J A Ferry1, J Sklar, L R Zukerberg
1James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Boston 02114.
The American Journal of Surgical Pathology
|March 1, 1991
Summary
Nasal cavity lymphomas are often diffuse, large-cell types, frequently angioinvasive and T-cell predominant. Radiation therapy shows a good prognosis for these malignant lymphomas.
Area of Science:
- Oncology
- Pathology
- Immunology
Background:
- Malignant lymphoma can involve the nasal cavity, presenting unique diagnostic and prognostic challenges.
- Understanding the specific subtypes and characteristics of sinonasal lymphomas is crucial for effective treatment.
Purpose of the Study:
- To analyze the clinicopathologic features of malignant lymphomas involving the nasal cavity.
- To determine the immunophenotype and treatment outcomes for these tumors.
Main Methods:
- Retrospective review of 13 nasal cavity lymphoma cases.
- Immunohistochemical and genotypic analyses for T-cell receptor gene rearrangement.
- Evaluation of treatment modalities including radiation therapy and chemotherapy.
Main Results:
- 13 cases studied (6 male, 7 female; age 27-92).
- Predominantly diffuse, large-cell lymphomas (10/13), often angioinvasive with necrosis (10/13).
- T-cell lineage identified in 4/9 cases; B-cell lineage in 2/9.
- 62% (8/13) disease-free survival with radiation therapy; 3/5 relapsed cases salvaged.
Conclusions:
- Nasal cavity lymphomas frequently exhibit angioinvasion and T-cell predominance.
- Radiation therapy appears to be an effective treatment modality, offering a relatively good prognosis.
- Further research into T-cell lymphomas of the nasal cavity is warranted.